Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
Albumin Assisted Diuresis in Patients with Cirrhosis Decompensated by Ascites and Peripheral Edema, a Proof-of-concept Double Blind Randomized Trial
Sponsor: Anahita Rabiee MD MHS
Listed as NCT06812390, this PHASE2 trial focuses on Ascites Hepatic and Cirrhosis and remains actively recruiting participants. Sponsored by Anahita Rabiee MD MHS, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Apr 2025 — Present [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Mar 2025 — Apr 2025 [monthly]
Not Yet Recruiting PHASE2
First recorded
Feb 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Anahita Rabiee MD MHS
- Grifols Shared Services North America Inc
For direct contact, visit the study record on ClinicalTrials.gov .